Tivozanib plus nivolumab had similar patient-reported outcomes to tivozanib alone in advanced kidney cancer after prior ...
Belzutifan plus cabozantinib maintained durable antitumor activity in advanced clear cell renal cell carcinoma, per phase 3 ...
Orca-T with reduced-intensity stem cell transplantation was a safe, feasible alternative to conventional transplant in blood ...
Mariam F. Eskander, MD, MPH, and Coral O. Omene, MD, PhD, discuss some specific practices and policies that have been most effective at their institution and how these may be adopted by other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results